The Venture Codex Logo

The Venture Codex

Overview

Precision oncology company developing targeted therapies for cancer.

Total Raised

$81 M

Rounds

2

Links

Verticals

Biopharma
Biotechnology
Clinical Trials
Health Care
Oncology
Pharmaceutical
...

Investment History

  1. Series B

    Sep 2020

    $63M

  2. Series A

    May 2018

    $18M

Team

Avanish Vellanki

Chairman & Ceo

Nelson Cabatuan

SVP Finance and Operations

Ranga Yarlagadda

Director of Corporate Development

Dharmendra Singh

Senior Scientist